Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Biliary Tract Diseases

Free Subscription Articles published in PLoS One Retrieve available abstracts of 91 articles: HTML format

Single Articles

January 2024
1. LIU Z, Shao Y, Duan X
   Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.
   PLoS One. 2024;19:e0298225.
   PubMed     Abstract available
   
   
   
2. DI CARLO P, Serra N, Fasciana TMA, Giammanco A, et al
   Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
   PLoS One. 2024;19:e0294049.
   PubMed     Abstract available
   
   
   
3. BAGER P, Bossen L, Gantzel R, Gronbaek H, et al
   High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial.
   PLoS One. 2024;19:e0301354.
   PubMed     Abstract available
   
   
   
4. GUPTA K, Xu JP, Diamond T, de Jong IEM, et al
   Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring: Evidence for a spectrum of neonatal injury.
   PLoS One. 2024;19:e0301824.
   PubMed     Abstract available
   
   
   
5. BEKRIC D, Kiesslich T, Ocker M, Winklmayr M, et al
   The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells.
   PLoS One. 2024;19:e0302050.
   PubMed     Abstract available
   
   
   January 2023
6. TANAKA R, Eguchi S, Kimura K, Ohira G, et al
   Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer.
   PLoS One. 2023;18:e0280348.
   PubMed     Abstract available
   
   
   
7. RUDIMAN R, Hanafi RV, Almawijaya, Halim F, et al
   Complications of biliary stenting versus T-tube insertion after common bile duct exploration: A systematic review and meta-analysis.
   PLoS One. 2023;18:e0280755.
   PubMed     Abstract available
   
   
   
8. HUANG L, Li S, Chen J, Zhu Y, et al
   Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis.
   PLoS One. 2023;18:e0280691.
   PubMed     Abstract available
   
   
   
9. GOOKIN JL, Hartley AN, Aicher KM, Mathews KG, et al
   Gallbladder microbiota in healthy dogs and dogs with mucocele formation.
   PLoS One. 2023;18:e0281432.
   PubMed     Abstract available
   
   
   
10. YOSHIDA M, Naitoh I, Hayashi K, Hori Y, et al
    Theoretical step approach with 'Three-pillar' device assistance for successful endoscopic transpapillary gallbladder drainage.
    PLoS One. 2023;18:e0281605.
    PubMed     Abstract available
    
    
    
11. ZHOU T, Wei H, Wang J
    Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid.
    PLoS One. 2023;18:e0279431.
    PubMed     Abstract available
    
    
    
12. WONGKANONG C, Patumanond J, Ratanachu-Ek T, Junrungsee S, et al
    Development of clinical prediction rule for the requirement of endoscopic papillary large balloon dilation (EPLBD) on endoscopic CBD stone clearance.
    PLoS One. 2023;18:e0282899.
    PubMed     Abstract available
    
    
    
13. INOUE T, Kutsumi H, Ibusuki M, Yoneda M, et al
    Endoscopic biliary ethanol ablation using a novel multi-hole balloon catheter: In vivo feasibility study in a swine model.
    PLoS One. 2023;18:e0283733.
    PubMed     Abstract available
    
    
    
14. YANG S, Qin L, Wu P, Liu Y, et al
    RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation.
    PLoS One. 2023;18:e0283770.
    PubMed     Abstract available
    
    
    
15. YE Y, Lui VCH, Babu RO, Wu Z, et al
    Identification of cancer-related genes FGFR2 and CEBPB in choledochal cyst via RNA sequencing of patient-derived liver organoids.
    PLoS One. 2023;18:e0283737.
    PubMed     Abstract available
    
    
    
16. HAN X, Wang J, Wu Y, Gu H, et al
    Predictive value of bile acids as metabolite biomarkers for gallstones: A protocol of systematic review and meta-analysis.
    PLoS One. 2023;18:e0284138.
    PubMed     Abstract available
    
    
    
17. POUDEL SK, Padmanabhan R, Dave H, Guinta K, et al
    Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease.
    PLoS One. 2023;18:e0283021.
    PubMed     Abstract available
    
    
    
18. JANNONE G, de Magnee C, Tambucci R, Evraerts J, et al
    Premature senescence of the liver in Alagille patients.
    PLoS One. 2023;18:e0285019.
    PubMed     Abstract available
    
    
    
19. KIM MH, Lee EJ, Kim SJ, Jung YJ, et al
    Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression.
    PLoS One. 2023;18:e0287146.
    PubMed     Abstract available
    
    
    
20. SIDDIQUI MA, Dwivedi N, Siddiqui MH, Rana SV, et al
    NMR spectroscopy-based analysis of gallstones of cancerous and benign gallbladders from different geographical regions of the Indian subcontinent.
    PLoS One. 2023;18:e0286979.
    PubMed     Abstract available
    
    
    
21. MAYR C, Kiesslich T, Bekric D, Beyreis M, et al
    Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.
    PLoS One. 2023;18:e0287769.
    PubMed     Abstract available
    
    
    
22. NEROLDOVA M, Ciara E, Slatinska J, Frankova S, et al
    Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.
    PLoS One. 2023;18:e0288907.
    PubMed     Abstract available
    
    
    
23. KUNIYOSHI N, Imazu H, Masuzaki R, Yamazaki M, et al
    Diagnostic utility of quantitative analysis of microRNA in bile samples obtained during endoscopic retrograde cholangiopancreatography for malignant biliary strictures.
    PLoS One. 2023;18:e0289537.
    PubMed     Abstract available
    
    
    
24. IWAMOTO T, Suda T, Inoue T, Nozaki Y, et al
    Postoperative bleeding after percutaneous transhepatic gallbladder drainage and aspiration in patients receiving antithrombotic therapy.
    PLoS One. 2023;18:e0288463.
    PubMed     Abstract available
    
    
    
25. SHEARN CT, Anderson AL, Devereaux MW, El Kasmi KC, et al
    Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition.
    PLoS One. 2023;18:e0290385.
    PubMed     Abstract available
    
    
    
26. GOINS EC, Wein LE, Watkins VY, Campbell AIK, et al
    Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts.
    PLoS One. 2023;18:e0293030.
    PubMed     Abstract available
    
    
    
27. PHAM HN, Pham L, Sato K
    Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
    PLoS One. 2023;18:e0292998.
    PubMed     Abstract available
    
    
    
28. HAYASHI H, Shimizu A, Kubota K, Notake T, et al
    Impact of sarcopenic obesity on post-hepatectomy bile leakage for hepatocellular carcinoma.
    PLoS One. 2023;18:e0286353.
    PubMed     Abstract available
    
    
    
29. YUK JS, Park JY
    Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
    PLoS One. 2023;18:e0294356.
    PubMed     Abstract available
    
    
    January 2022
30. SONGSERM N, Woradet S, Kankarn W, Pintakham K, et al
    Cholangiocarcinoma protective factors in Greater Mekong Subregion: Critical issues for joint planning to sustainably solve regional public health problems.
    PLoS One. 2022;17:e0262589.
    PubMed     Abstract available
    
    
    
31. LIU B, Zhang J, Shao L, Yao J, et al
    Network pharmacology analysis and molecular docking to unveil the potential mechanisms of San-Huang-Chai-Zhu formula treating cholestasis.
    PLoS One. 2022;17:e0264398.
    PubMed     Abstract available
    
    
    
32. YAMAMOTO Y, Sugimoto A, Maruo K, Tsujio G, et al
    CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
    PLoS One. 2022;17:e0266027.
    PubMed     Abstract available
    
    
    
33. LEE TW, Bae W, Kim S, Choi J, et al
    Incidence, risk factors, and prognosis of acute kidney injury in hospitalized patients with acute cholangitis.
    PLoS One. 2022;17:e0267023.
    PubMed     Abstract available
    
    
    
34. SONG J, Lei X, Lin H, Dai H, et al
    Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.
    PLoS One. 2022;17:e0258522.
    PubMed     Abstract available
    
    
    
35. KALOGEROPOULU SK, Lloyd EJ, Rauch H, Redtenbacher I, et al
    Chronic cholecystitis: Diagnostic and therapeutic insights from formerly bile-farmed Asiatic black bears (Ursus thibetanus).
    PLoS One. 2022;17:e0264391.
    PubMed     Abstract available
    
    
    
36. ISHII M, Itano O, Morinaga J, Shirakawa H, et al
    Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
    PLoS One. 2022;17:e0266707.
    PubMed     Abstract available
    
    
    
37. UDOMSINPRASERT W, Ungsudechachai T, Vejchapipat P, Poovorawan Y, et al
    Systemic cytokine profiles in biliary atresia.
    PLoS One. 2022;17:e0267363.
    PubMed     Abstract available
    
    
    
38. LI J, Cen W, Tong C, Wang L, et al
    Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis.
    PLoS One. 2022;17:e0266738.
    PubMed     Abstract available
    
    
    
39. SANGSUWANNUKUL T, Supimon K, Chieochansin T, Choomee K, et al
    Antitumor activity of T cells secreting alphaCD133-alphaCD3 bispecific T-cell engager against cholangiocarcinoma.
    PLoS One. 2022;17:e0265773.
    PubMed     Abstract available
    
    
    
40. ZHANG G, Liu X, Jian A, Zheng K, et al
    CHST4 might promote the malignancy of cholangiocarcinoma.
    PLoS One. 2022;17:e0265069.
    PubMed     Abstract available
    
    
    
41. WANG J, Zhao Q, Chen B, Sun J, et al
    Risk factors for metabolic bone disease of prematurity: A meta-analysis.
    PLoS One. 2022;17:e0269180.
    PubMed     Abstract available
    
    
    
42. WANG GY, Garcia V, Lee J, Yanum J, et al
    Nrf2 deficiency causes hepatocyte dedifferentiation and reduced albumin production in an experimental extrahepatic cholestasis model.
    PLoS One. 2022;17:e0269383.
    PubMed     Abstract available
    
    
    
43. XU W, Zhang M, Liu L, Yin M, et al
    Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0269612.
    PubMed     Abstract available
    
    
    
44. JIANG Y, Zhang Y, Yang Q, Zeng D, et al
    The association between fetal fraction and pregnancy-related complications among Chinese population.
    PLoS One. 2022;17:e0271219.
    PubMed     Abstract available
    
    
    
45. RICHTER B, Sanger C, Mussbach F, Scheuerlein H, et al
    Species specific morphological alterations in liver tissue after biliary occlusion in rat and mouse: Similar but different.
    PLoS One. 2022;17:e0271975.
    PubMed     Abstract available
    
    
    
46. PAUSAWASDI N, Termsinsuk P, Charatcharoenwitthaya P, Limsrivilai J, et al
    Development and validation of a risk score for predicting clinical success after endobiliary stenting for malignant biliary obstruction.
    PLoS One. 2022;17:e0272918.
    PubMed     Abstract available
    
    
    
47. HOLM M, Joenvaara S, Saraswat M, Tohmola T, et al
    Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis.
    PLoS One. 2022;17:e0272810.
    PubMed     Abstract available
    
    
    
48. KOO T, Cheong KH, Kim K, Park HJ, et al
    Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer.
    PLoS One. 2022;17:e0273395.
    PubMed     Abstract available
    
    
    
49. HSU FR, Dai ST, Chou CM, Huang SY, et al
    The application of artificial intelligence to support biliary atresia screening by ultrasound images: A study based on deep learning models.
    PLoS One. 2022;17:e0276278.
    PubMed     Abstract available
    
    
    
50. SUKSURATIN P, Rodpai R, Luvira V, Intapan PM, et al
    Rapid label-free detection of cholangiocarcinoma from human serum using Raman spectroscopy.
    PLoS One. 2022;17:e0275362.
    PubMed     Abstract available
    
    
    
51. SCHMITZ D, Valiente CT, Dollhopf M, Perez-Miranda M, et al
    Percutaneous transhepatic or endoscopic ultrasound-guided biliary drainage in malignant distal bile duct obstruction using a self-expanding metal stent: Study protocol for a prospective European multicenter trial (PUMa trial).
    PLoS One. 2022;17:e0275029.
    PubMed     Abstract available
    
    
    
52. PARK SE, Nam IC, Baek HJ, Ryu KH, et al
    Effectiveness of ultrasound-guided percutaneous transhepatic biliary drainage to reduce radiation exposure: A single-center experience.
    PLoS One. 2022;17:e0277272.
    PubMed     Abstract available
    
    
    
53. SHEARN CT, Anderson AL, Devereux MW, Orlicky DJ, et al
    The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease.
    PLoS One. 2022;17:e0276879.
    PubMed     Abstract available
    
    
    
54. MUHAMAD N, Plengsuriyakarn T, Na-Bangchang K
    Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice.
    PLoS One. 2022;17:e0277614.
    PubMed     Abstract available
    
    
    
55. LAOCHAREONSUK W, Surachat K, Chiengkriwate P, Sangkhathat S, et al
    A novel pathogenesis concept of biliary atresia approached by combined molecular strategies.
    PLoS One. 2022;17:e0277334.
    PubMed     Abstract available
    
    
    
56. FARKKILA M, Kautiainen H, Tenca A, Jokelainen K, et al
    PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis.
    PLoS One. 2022;17:e0277084.
    PubMed     Abstract available
    
    
    
57. HIGASHIZONO K, Nakatani E, Hawke P, Fujimoto S, et al
    Risk factors for gallstone disease onset in Japan: Findings from the Shizuoka Study, a population-based cohort study.
    PLoS One. 2022;17:e0274659.
    PubMed     Abstract available
    
    
    January 2021
58. FENG J, Wu R, Zhang G, Yang Z, et al
    Prognostic importance of numbers of retrieved lymph nodes and positive lymph nodes for ampulla of vater cancer (AVC) in 2347 patients from the Surveillance, Epidemiology, and End Results (SEER) database.
    PLoS One. 2021;16:e0244987.
    PubMed     Abstract available
    
    
    
59. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    PubMed     Abstract available
    
    
    
60. TAYLOR SA, Chen SY, Gadhvi G, Feng L, et al
    Transcriptional profiling of pediatric cholestatic livers identifies three distinct macrophage populations.
    PLoS One. 2021;16:e0244743.
    PubMed     Abstract available
    
    
    
61. NOGUCHI D, Kuriyama N, Nakagawa Y, Maeda K, et al
    The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers.
    PLoS One. 2021;16:e0245946.
    PubMed     Abstract available
    
    
    
62. YASUKAWA K, Shimizu A, Motoyama H, Kubota K, et al
    Applicability of sentinel lymph node oriented treatment strategy for gallbladder cancer.
    PLoS One. 2021;16:e0247079.
    PubMed     Abstract available
    
    
    
63. THANEE M, Dokduang H, Kittirat Y, Phetcharaburanin J, et al
    CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression.
    PLoS One. 2021;16:e0245871.
    PubMed     Abstract available
    
    
    
64. KOVAC JD, Dakovic M, Jankovic A, Mitrovic M, et al
    The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    PLoS One. 2021;16:e0247301.
    PubMed     Abstract available
    
    
    
65. PARK JW, Jeong JM, Cho KS, Cho SY, et al
    MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases.
    PLoS One. 2021;16:e0250083.
    PubMed     Abstract available
    
    
    
66. SO H, Oh CH, Song TJ, Ko SW, et al
    Predictors of stent dysfunction in patients with bilateral metal stents for malignant hilar obstruction.
    PLoS One. 2021;16:e0249096.
    PubMed     Abstract available
    
    
    
67. MIHARA K, Matsuda S, Nakamura Y, Aiura K, et al
    Intraoperative laparoscopic detection of sentinel lymph nodes with indocyanine green and superparamagnetic iron oxide in a swine gallbladder cancer model.
    PLoS One. 2021;16:e0248531.
    PubMed     Abstract available
    
    
    
68. TANG W, Qiu JG, Deng X, Liu SS, et al
    Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness.
    PLoS One. 2021;16:e0248534.
    PubMed     Abstract available
    
    
    
69. SAAB M, Mestivier D, Sohrabi M, Rodriguez C, et al
    Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.
    PLoS One. 2021;16:e0247798.
    PubMed     Abstract available
    
    
    
70. KIM MU, Lee Y, Lee JH, Cho SB, et al
    Predictive factors affecting percutaneous drainage duration in the percutaneous treatment of common bile duct stones.
    PLoS One. 2021;16:e0248003.
    PubMed     Abstract available
    
    
    
71. TAKADA N, Sugano H, Shirai Y, Saito N, et al
    Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    PLoS One. 2021;16:e0257019.
    PubMed     Abstract available
    
    
    
72. KOH M, Park JH, Yoo C, Yoon SM, et al
    Radiation therapy for recurrent extrahepatic bile duct cancer.
    PLoS One. 2021;16:e0253285.
    PubMed     Abstract available
    
    
    
73. LENDVAI G, Szekerczes T, Illyes I, Csengeri M, et al
    Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
    PLoS One. 2021;16:e0253065.
    PubMed     Abstract available
    
    
    
74. CHUNG HG, Chang JI, Lee KH, Park JK, et al
    Comparison of EUS and ERCP-guided tissue sampling in suspected biliary stricture.
    PLoS One. 2021;16:e0258887.
    PubMed     Abstract available
    
    
    
75. MARINI TJ, Oppenheimer DC, Baran TM, Rubens DJ, et al
    Testing telediagnostic right upper quadrant abdominal ultrasound in Peru: A new horizon in expanding access to imaging in rural and underserved areas.
    PLoS One. 2021;16:e0255919.
    PubMed     Abstract available
    
    
    
76. POOSEKEAW P, Pairojkul C, Sripa B, Sa Ngiamwibool P, et al
    Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
    PLoS One. 2021;16:e0259075.
    PubMed     Abstract available
    
    
    
77. KOKAS B, Szijarto A, Farkas N, Ujvary M, et al
    Percutaneous transhepatic drainage is safe and effective in biliary obstruction-A single-center experience of 599 patients.
    PLoS One. 2021;16:e0260223.
    PubMed     Abstract available
    
    
    January 2020
78. ZIZALOVA K, Vecka M, Vitek L, Lenicek M, et al
    Enzymatic methods may underestimate the total serum bile acid concentration.
    PLoS One. 2020;15:e0236372.
    PubMed     Abstract available
    
    
    
79. TASKIN OC, Basturk O, Reid MD, Dursun N, et al
    Gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions.
    PLoS One. 2020;15:e0237979.
    PubMed     Abstract available
    
    
    
80. CHANG TT, Ho CH
    Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2020;15:e0238251.
    PubMed     Abstract available
    
    
    
81. HAYASHI M, Abe K, Fujita M, Takahashi A, et al
    Association between serum ficolin-1 level and disease progression in primary biliary cholangitis.
    PLoS One. 2020;15:e0238300.
    PubMed     Abstract available
    
    
    
82. KOJIMA T, Umeda Y, Fuji T, Niguma T, et al
    Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
    PLoS One. 2020;15:e0238392.
    PubMed     Abstract available
    
    
    
83. FUJIWARA K, Masatsugu T, Abe A, Hirano T, et al
    Preoperative diagnoses and identification rates of unexpected gallbladder cancer.
    PLoS One. 2020;15:e0239178.
    PubMed     Abstract available
    
    
    
84. SUN R, Zhao N, Zhao K, Su Z, et al
    Comparison of efficacy and safety of laparoscopic excision and open operation in children with choledochal cysts: A systematic review and update meta-analysis.
    PLoS One. 2020;15:e0239857.
    PubMed     Abstract available
    
    
    
85. THOMSEN H, Li X, Sundquist K, Sundquist J, et al
    Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.
    PLoS One. 2020;15:e0240794.
    PubMed     Abstract available
    
    
    
86. KIM TH, Park DE, Chon HK
    Endoscopic transpapillary gallbladder drainage for the management of acute calculus cholecystitis patients unfit for urgent cholecystectomy.
    PLoS One. 2020;15:e0240219.
    PubMed     Abstract available
    
    
    
87. FENG L, Dong K, Zhang X, Ma B, et al
    Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
    PLoS One. 2020;15:e0242164.
    PubMed     Abstract available
    
    
    
88. SHIN J, Wood LD, Hruban RH, Hong SM, et al
    Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers.
    PLoS One. 2020;15:e0242571.
    PubMed     Abstract available
    
    
    
89. CHIU TJ, Chen YJ, Kuo FY, Chen YY, et al
    Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2020;15:e0240791.
    PubMed     Abstract available
    
    
    
90. MOLE DJ, Fallowfield JA, Sherif AE, Kendall T, et al
    Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.
    PLoS One. 2020;15:e0238568.
    PubMed     Abstract available
    
    
    
91. JAFFEY JA, Matheson J, Shumway K, Pacholec C, et al
    Serum 25-hydroxyvitamin D concentrations in dogs with gallbladder mucocele.
    PLoS One. 2020;15:e0244102.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.